Literature DB >> 7082862

Further studies on factor VII Padua defect: the report of the fourth homozygous patient from the same valley.

A Girolami, A Gaio, L Doglioni, M Procidano, P Saltarin.   

Abstract

A new patient with factor VII Padua abnormality is presented. The proposita is an 11-year-old girl who showed a mild bleeding tendency and a laboratory pattern characterized by a prolonged prothrombin time corrected by normal serum, normal partial thromboplastin time and normal Thrombotest. Factor VII assay was 10% using rabbit brain thromboplastin and 100% of normal using ox brain thromboplastin. Factor VII cross-reaction material was normal. The parents were not consanguineous but both came from the same area and were found to be heterozygous for the abnormality. The discovery of the present patient, the fourth in three years, indicates that the defect might be more frequent than originally thought.

Entities:  

Mesh:

Year:  1982        PMID: 7082862     DOI: 10.1007/BF00319920

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  13 in total

1.  Congenital SPCA deficiency: a hitherto unrecognized coagulation defect with hemorrhage rectified by serum and serum fractions.

Authors:  B ALEXANDER; R GOLDSTEIN; G LANDWEHR; C D COOK
Journal:  J Clin Invest       Date:  1951-06       Impact factor: 14.808

2.  Factor VII verona coagulation disorder: double heterozygosis with an abnormal factor VII and heterozygous factor VII deficiency.

Authors:  A Girolami; G Falezza; G Patrassi; M Stenico; L Vettore
Journal:  Blood       Date:  1977-10       Impact factor: 22.113

3.  A CRM-Positive variant of factor-VII deficiency and the detection of heterozygotes with the assay of factor-like antigen.

Authors:  M G Mazzucconi; F Mandelli; G Mariani; E Briët; J J Veltkamp
Journal:  Br J Haematol       Date:  1977-05       Impact factor: 6.998

4.  Genetic variants of factor VII.

Authors:  K W Denson; J Conard; M Samama
Journal:  Lancet       Date:  1972-06-03       Impact factor: 79.321

5.  Dilution curve studies in prothrombin complex factors deficiencies and abnormalities.

Authors:  A Girolami; A Brunetti; L DeMarco; D Fioretti
Journal:  Blut       Date:  1974-08

6.  Factor VII antibody-neutralizing material in hereditary and acquired factor VII deficiency.

Authors:  S H Goodnight; D I Feinstein; B Osterud; S I Rapaport
Journal:  Blood       Date:  1971-07       Impact factor: 22.113

7.  Active and inactive factor VII in Dubin-Johnson syndrome with factor-VII deficiency, hereditary factor-VII deficiency and on coumadin administration.

Authors:  M Levanon; S Rimon; M Shani; B Ramot; E Goldberg
Journal:  Br J Haematol       Date:  1972-12       Impact factor: 6.998

8.  Factor VII Padua 2: another factor VII abnormality with defective ox brain thromboplastin activation and a complex hereditary pattern.

Authors:  A Girolami; G Cattarozzi; R Dal Bo Zanon; F Toffanin
Journal:  Blood       Date:  1979-07       Impact factor: 22.113

9.  Molecular variant of factor VII.

Authors:  E Briët; E A Loeliger; N H Van Tilburg; J J Veltkamp
Journal:  Thromb Haemost       Date:  1976-04-30       Impact factor: 5.249

10.  Congenital hypoproconvertinemia (factor VII deficiency). A report of two cases belonging to two different kindreds.

Authors:  A Girolami; P Scorza; A Brunetti; C Morgagni; G Santini
Journal:  Acta Haematol       Date:  1973-10       Impact factor: 2.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.